Updates are available Correction dated 2021-04-27
Click to view Correction: https://doi.org/10.1038/s41431-021-00895-w
-
Authors
Yelskaya, Zarina
Arnold, Angela G.
Marcell, Vanessa J. http://orcid.org/0000-0003-4166-6071
Tang, Laura H.
Salo-Mullen, Erin E.
Strong, Vivian E.
Stadler, Zsofia K.
Zhang, Liying http://orcid.org/0000-0003-4517-0751
-
Funding
Funding for this research was provided by:
Department of Pathology, Memorial Sloan Kettering Cancer Center
- License Information
-
More Information
Article History
Received: 28 July 2020
Revised: 25 January 2021
Accepted: 29 January 2021
First Online: 22 February 2021
Change Date: 27 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41431-021-00895-w
Compliance with ethical standards
:
: LZ: Honoraria (Future Technology Research LLC, BGI, Illumina); Honoraria and Travel and accommodation expenses (Roche Diagnostics Asia Pacific). Family members hold leadership position and ownership interest of Decipher Medicine. ZKS: Immediate family member serves as a consultant for Allergan, Adverum Biotechnologies, Alimera Sciences, Fortress Biotech, Genentech/Roche, Novartis, Optos, Regeneron, Regenxbio, and Spark Therapeutics.
